These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. [Biological therapy as treatment of inflammatory bowel diseases]. Agnholt J. Ugeskr Laeger; 2008 Jun 09; 170(24):2152-6. PubMed ID: 18565302 [Abstract] [Full Text] [Related]
5. The London Position Statement of the World Congress of Gastroenterology on Biological Therapy for IBD with the European Crohn's and Colitis Organization: when to start, when to stop, which drug to choose, and how to predict response? D'Haens GR, Panaccione R, Higgins PD, Vermeire S, Gassull M, Chowers Y, Hanauer SB, Herfarth H, Hommes DW, Kamm M, Löfberg R, Quary A, Sands B, Sood A, Watermeyer G, Lashner B, Lémann M, Plevy S, Reinisch W, Schreiber S, Siegel C, Targan S, Watanabe M, Feagan B, Sandborn WJ, Colombel JF, Travis S. Am J Gastroenterol; 2011 Feb 09; 106(2):199-212; quiz 213. PubMed ID: 21045814 [Abstract] [Full Text] [Related]
6. Appropriateness of immunosuppressive drugs in inflammatory bowel diseases assessed by RAND method: Italian Group for IBD (IG-IBD) position statement. Caprilli R, Angelucci E, Cocco A, Viscido A, Annese V, Ardizzone S, Biancone L, Castiglione F, Cottone M, Meucci G, Paoluzi P, Papi C, Sturniolo GC, Vecchi M. Dig Liver Dis; 2005 Jun 09; 37(6):407-17. PubMed ID: 15893279 [Abstract] [Full Text] [Related]
7. Tumor necrosis factor-α monoclonal antibodies in the treatment of inflammatory bowel disease: clinical practice pharmacology. Lee TW, Fedorak RN. Gastroenterol Clin North Am; 2010 Sep 09; 39(3):543-57. PubMed ID: 20951917 [Abstract] [Full Text] [Related]
9. [Compared azathioprine efficacy in ulcerative colitis and in Crohn's disease]. Kull E, Beau P. Gastroenterol Clin Biol; 2002 Apr 09; 26(4):367-71. PubMed ID: 12070412 [Abstract] [Full Text] [Related]
10. [Treatment of ulcerative colitis and Crohn's disease with monoclonal antibody]. Asakura H. Nihon Rinsho; 2002 Mar 09; 60(3):531-8. PubMed ID: 11904969 [Abstract] [Full Text] [Related]
12. Addition of thiopurines can recapture response in patients with Crohn's disease who have lost response to anti-tumor necrosis factor monotherapy. Ong DE, Kamm MA, Hartono JL, Lust M. J Gastroenterol Hepatol; 2013 Oct 09; 28(10):1595-9. PubMed ID: 23662928 [Abstract] [Full Text] [Related]
16. T-cell non-Hodgkin's lymphomas reported to the FDA AERS with tumor necrosis factor-alpha (TNF-α) inhibitors: results of the REFURBISH study. Deepak P, Sifuentes H, Sherid M, Stobaugh D, Sadozai Y, Ehrenpreis ED. Am J Gastroenterol; 2013 Jan 09; 108(1):99-105. PubMed ID: 23032984 [Abstract] [Full Text] [Related]